Home › Cancro al rene (carcinoma a cellule renali) › Tennessee › Nashville
Studi clinici su Cancro al rene (carcinoma a cellule renali) a Nashville, TN
23 studi su Cancro al rene (carcinoma a cellule renali) cercano partecipanti presso sedi a Nashville e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors
In reclutamentoFase 1
- Research Site, Nashville
- Research Site, Nashville
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
In reclutamentoFase 1
- Tennessee Oncology, Nashville
A Phase 1 Study of the Safety and Tolerability of CTX-10726
In reclutamentoFase 1
- SCRI Oncology Partners, Nashville
Substudy 03C: A Study of Combination Therapies in Participants With Renal Cell Carcinoma With Recurrent Disease During or After Anti-PD-(L)1 Therapy (MK-3475-03C/KEYMAKER-U03)
In reclutamentoFase 1/2
- Vanderbilt University Medical Center ( Site 5004), Nashville
A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma
In reclutamentoFase 1
- Sarah Cannon Research Institute (SCRI), Nashville
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
In reclutamentoFase 1
- Exelixis Clinical Site #3, Nashville
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
In reclutamentoFase 2
- Vanderbilt University/Ingram Cancer Center, Nashville
DESTINY-PANTUMOUR04
In reclutamentoStudio osservazionale
- Research Site, Nashville
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
In reclutamentoStudio osservazionale
- Vanderbilt University Medical Center, Nashville
Casdatifan for the Treatment of Refractory Metastatic Clear Cell Renal Cell Carcinoma
In reclutamentoFase 1
- Vanderbilt University Medical Center, Nashville
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
In reclutamentoFase 1/2
- Vanderbilt University Medical Center, Nashville
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
In reclutamentoFase 1/2
- Sarah Cannon Research Institute, Nashville
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
In reclutamentoFase 1/2
- Sarah Cannon Research Institute, Nashville
- SCRI Oncology Partners, Nashville
- Tennessee Oncology, PLLC- Elliston Place Plaza, Nashville
- e altri 11
A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies
In reclutamentoFase 1
- Scri Oncology Partners, Nashville
- Vanderbilt Medical Center, Nashville
A Randomized Trial of Fianlimab and Cemiplimab +/- Ipilimumab or Ipilimumab Plus Nivolumab in First-line Advanced Renal Cell Carcinoma (RCC)
In reclutamentoFase 2
- Vanderbilt-Ingram Cancer Center, Nashville
Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer
In reclutamentoFase 3
- Vanderbilt University/Ingram Cancer Center, Nashville
Genetic Testing to Select Therapy for the Treatment of Advanced or Metastatic Kidney Cancer, OPTIC RCC Study
In reclutamentoFase 2
- Vanderbilt University/Ingram Cancer Center, Nashville
Study of DCC-2812 in Participants With Advanced Genitourinary Cancers
In reclutamentoFase 1
- Vanderbilt- Ingram Cancer Center, Nashville
A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
In reclutamentoFase 1/2
- Vanderbilt University Medical Center, Nashville
A First-in-Human Study of BMS-986506 in Participants With Advanced Clear Cell Renal Cell Carcinoma (ccRCC)
In reclutamentoFase 1
- SCRI Oncology Partners, Nashville
Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma
In reclutamentoFase 1
- Xencor Investigative Site, Nashville
KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
In reclutamentoFase 1
- SCRI - Oncology Partners, Nashville
Pilot Study of Bone Mineral Density Changes During Anti-PD-1 Immunotherapy
In reclutamento
- Vanderbilt-Ingram Cancer Center, Nashville
Studi su Cancro al rene (carcinoma a cellule renali) in altre città
- Houston, TX35 studi
- New York City, NY27 studi
- Dallas, TX23 studi
- St. Louis, MO23 studi
- Los Angeles, CA20 studi
- Boston, MA16 studi
- Baldwin Park, CA16 studi
- Pittsburgh, PA15 studi
- Philadelphia, PA15 studi
- Queens, NY15 studi
- Cleveland, OH14 studi
- Rochester, MN14 studi
Altri studi a Nashville
- Cancro del polmone non a piccole cellule97 studi
- Cancro al seno81 studi
- Cancro metastatico70 studi
- Cancro colorettale69 studi
- Cancro (tutti i tipi)65 studi
- Cancro ovarico49 studi
- Cancro alla prostata43 studi
- Cancro ai polmoni40 studi
- Carcinoma a cellule squamose della testa e del collo39 studi
- Cancro pancreatico39 studi
- Cancro dell'endometrio38 studi
- Melanoma33 studi
Fonte: ClinicalTrials.gov, dati recuperati il 6 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.